Condition

Bevacizimab clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Bevacizimab clinical trials that are recruiting, at sites in 2 countries (most in China (2), United States (1)). By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Bevacizimab clinical trials

StudyPhaseWhereStatusRegistered
Bevacizumab for severe HHT-related nosebleeds Phase 2 Hangzhou, Zhejiang Recruiting Sep 18, 2026
SAR445877 with FOLFOX6 and bevacizumab as first-line treatment for MSS metastatic colorectal cancer Phase 1 Houston, Texas Recruiting Mar 30, 2026
Sintilimab plus bevacizumab biosimilar before surgery for resectable liver cancer Phase 2 Guangzhou, Guangdong Recruiting Jan 8, 2026

All recruiting trials (3)

Related topics

BevacizumabFirst-line TreatmentHepatocellular CarcinomaMetastatic Colorectal Cancer (CRC)Neoadjuvant TherapyPhase 1SintilimabSintilimab

Quick answers

How many Bevacizimab clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.